BE713698A - - Google Patents

Info

Publication number
BE713698A
BE713698A BE713698DA BE713698A BE 713698 A BE713698 A BE 713698A BE 713698D A BE713698D A BE 713698DA BE 713698 A BE713698 A BE 713698A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE713698A publication Critical patent/BE713698A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE713698D 1967-04-13 1968-04-12 BE713698A (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63049767A 1967-04-13 1967-04-13
US69442167A 1967-12-29 1967-12-29

Publications (1)

Publication Number Publication Date
BE713698A true BE713698A (en:Method) 1968-10-14

Family

ID=27091165

Family Applications (1)

Application Number Title Priority Date Filing Date
BE713698D BE713698A (en:Method) 1967-04-13 1968-04-12

Country Status (5)

Country Link
BE (1) BE713698A (en:Method)
CH (3) CH527828A (en:Method)
DE (1) DE1770135A1 (en:Method)
FR (2) FR1588463A (en:Method)
GB (1) GB1183135A (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380721A (en) * 1990-09-10 1995-01-10 Sterling Winthrop Inc. Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
TW245719B (en:Method) * 1990-09-10 1995-04-21 Sterling Winthrop Inc
CA2104060A1 (en) * 1992-11-10 1994-05-11 Robert Ed Johnson Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
GB9425701D0 (en) * 1994-12-20 1995-02-22 Wellcome Found Enzyme inhibitors
WO2005058311A1 (en) * 2003-12-15 2005-06-30 Schering Corporation Heterocyclic aspartyl protease inhibitors
EP1940828B1 (en) 2005-10-27 2010-08-18 Schering Corporation Heterocyclic aspartyl protease inhibitors

Also Published As

Publication number Publication date
CH511863A (de) 1971-08-31
CH527828A (de) 1972-09-15
FR1588463A (en:Method) 1970-04-17
GB1183135A (en) 1970-03-04
FR7495M (en:Method) 1969-12-08
DE1770135A1 (de) 1971-09-23
CH523264A (de) 1972-05-31

Similar Documents

Publication Publication Date Title
AU425114B2 (en:Method)
FR7495M (en:Method)
AU342066A (en:Method)
BE697306A (en:Method)
BE694668A (en:Method)
BE709526A (en:Method)
BE699145A (en:Method)
BE698868A (en:Method)
AU34866A (en:Method)
BE698863A (en:Method)
BE698820A (en:Method)
BE698436A (en:Method)
BE698191A (en:Method)
BE698128A (en:Method)
BE697691A (en:Method)
BE697353A (en:Method)
BE697230A (en:Method)
BE697014A (en:Method)
BE696824A (en:Method)
BE696685A (en:Method)
BE696478A (en:Method)
BE696474A (en:Method)
BE696449A (en:Method)
BE696358A (en:Method)
BE696163A (en:Method)